http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103937706-B

Outgoing Links

Predicate Object
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-35
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103937706-B
titleOfInvention Mycoplasma hyorhinis bacterial strain and inactivated vaccine thereof and application
abstract The invention discloses mycoplasma hyorhinis bacterial strain and inactivated vaccine thereof and application.The present invention utilizes the strain mycoplasma hyorhinis virulent strain that is separated to from pig farm, screening to cultivate, and immunogenicity is good, the mycoplasma hyorhinis virulent strain of titer plateaus, and its deposit number is: CGMCC NO.8701ï¼›When preparing inactivated vaccine with this virulent strain, present invention optimizes used inactivator kind, adjuvant kind and other process conditions.The present invention has carried out test determination to production technology, security, protective rate, immune programme for children, minimum dose, antibody duration and the storage life etc. of inactivated vaccine; inactivated vaccine prepared by the final certification present invention is safe and effective, can effectively prevent and treat the multiple diseases such as the pig polyserositis, pneumonia, pericarditis, pleurisy, arthritis or the tympanitis that are caused by mycoplasma hyorhinis.
priorityDate 2014-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68561600
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID85708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428054790
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID85708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID23211
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID23211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712

Total number of triples: 25.